reviewed by the authorized auditor of PricewaterhouseCooper ABAS Co.,Ltd. and approved by the Board of Directors of the Company on meeting No.2/2019 held on May 8, 2019 and also clarify the change of
work also decreased 7.02 million Baht, as the sub-contracting project nearly complete. Cost of good sold decreased 1.40%, it decreased in portion of revenue and nearly from last year. SG&A expenses and
Information and Other Acts of Listed Companies Concerning the Acquisition and Disposition of Assets, 2004 (as amended), is less than 15 percent and the total size of all transactions in the past 6 months also
. 4/2019 held on August 7, 2019. Also, on this occasion, the Company would like to report its operating results as detailed below:- 1. Total Revenue The total operating revenue of the Company and its
of the Board of Director No.1/201, which was held on February 21, 2018. Also, the Company had already informed the Stock Exchange of Thailand (SET) on February 22, 2018. The expansion of Wattanapat
by 11.15% from Baht 139.49 million to Baht 155.05 million. Revenue from Installation work also decreased by 67.57%, as the sub-contracting project nearly complete. SG&A expenses and interest expenses
total sales. While, the cost of sales in Q2/2018 was 346,016,951.10 Baht, representing 86.11 % of total sales. Also, the selling and administrative expenses in Q2/2019 increased 5,252,996.83, or 15.39
99.99996% 3. Mr. Amnuay Oerareemitr 1 0.00001% A director of the EKH, There is no conflict of interest because EKH does not operate an infertility center. It also promotes the business. 4. Mr. Amnuay
% shares, and also a major shareholder of SRD, direct holding 27% and indirect holding 13% shares. Transaction type LHMH and SRD will enter into an amendment to the agreement to be an advisor for sales and